T3 Beta-AT Injection
₹382.5*
MRP ₹425
10% off
₹361*
MRP ₹425
15% CB
₹64 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
T3 Beta-AT Injection belongs to the class of 'anti-malarial drugs', primarily used to treat malaria. Malaria is a disease caused by a plasmodium parasite, transmitted by the bite of infected Anopheles mosquitoes. When an infected mosquito bites a healthy person, it transmits the 'Plasmodium parasite' into the bloodstream, which affects the red blood cells and liver cells. Malaria symptoms usually start 10 days to 4 weeks after the infection. They include chills, high fever, profuse sweating, headache, nausea, vomiting, abdominal pain, diarrhea, anemia, muscle pain, convulsions, coma, and bloody stools.
T3 Beta-AT Injection contains ‘Artesunate’. This T3 Beta-AT Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. T3 Beta-AT Injection is used to treat malaria caused by a parasite called 'Plasmodium falciparum,' another plasmodium species. It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.
T3 Beta-AT Injection will be administered by a healthcare professional; do not self-administer. You may experience dizziness, headache, weakness, and loss of appetite (not feeling hungry). Most of these side effects of T3 Beta-AT Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Before using T3 Beta-AT Injection, inform your doctor if you recently used any prescription and non-prescription medications, including other anti-malarial or antibiotic drugs. Let your doctor know if you are allergic to T3 Beta-AT Injection or its components. Inform your doctor if you have any liver or kidney problems. It is essential to let your doctor know if you are pregnant, planning to conceive, or are a breastfeeding mother. T3 Beta-AT Injection causes drowsiness and dizziness it is advisable to avoid driving unless you are alert.
T3 Beta-AT Injection contains ‘Artesunate’. This T3 Beta-AT Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. It is used to treat cerebral malaria and all kind of severe malaria. The antimalarial effect of T3 Beta-AT Injection is commonly identified as generally safe, highly efficient and well-tolerated. T3 Beta-AT Injection is used to treat malaria caused by a parasite called 'Plasmodium falciparum,' other plasmodium species. It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.
Inform your doctor if you have any allergic reactions to T3 Beta-AT Injection or its components. Brief your medical history to the doctor if you have any liver or kidney problems, or heart disease. Blood problems may occur after you receive treatment with this T3 Beta-AT Injection. Inform your doctor immediately if you or your child have pain in the leg, back, or stomach, chills, bleeding gums, difficulty breathing, dark urine, general body swelling, fever, loss of appetite (feeling not hungry), headache, nosebleeds, nausea, or vomiting, sore throat, pale skin, unusual tiredness or weakness, or yellow skin or eyes. Inform your doctor immediately if you or your child have chest tightness, blurred vision, cough, confusion, faintness, dizziness, or lightheadedness. When getting up unexpectedly from a sitting or lying position, skin rash, redness of the skin, itching, sweating, swelling of your face, hands, or mouth, trouble breathing or swallowing, or unusual weakness or tiredness after you receive this T3 Beta-AT Injection. It is essential to let your doctor know if you are pregnant, planning to conceive, or are a breastfeeding mother. T3 Beta-AT Injection causes drowsiness and dizziness it is advisable to avoid driving unless you are alert.
Drug-Drug Interactions: T3 Beta-AT Injection may interact with other anti-malarial drugs (mefloquine), medicines for HIV (pyrimethamine).
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Before using T3 Beta-AT Injection, let your doctor know if you have an allergy, heart disease, kidney disease, and liver disease.
Malaria: It is a life-threatening disease caused by parasites that enter the body through a mosquito's bite. This is a common disease in countries like Africa, South America, and Southern Asia. This disease usually occurs when an Anopheles mosquito (infected with the parasite 'Plasmodium') bites a healthy individual and transfers the parasite into the bloodstream. Parasites that cause malaria include Plasmodium vivax, P. ovale, P. malaria, and P. falciparum. Malaria symptoms usually start 10 days to 4 weeks after the infection. They include chills, high fever, profuse sweating, headache, nausea, vomiting, abdominal pain, diarrhea, anemia, muscle pain, convulsions, coma and bloody stools.
Alcohol
Caution
Avoid alcohol while using T3 Beta-AT Injection since it can worsen your side effects.
Pregnancy
Unsafe
T3 Beta-AT Injection is not safe during pregnancy as it causes severe side effects to both mother and unborn baby.
Breast Feeding
Caution
T3 Beta-AT Injection is present in breast milk but may not be expected to cause any side effects in the new-born baby especially more than 2 months. Please use only in the condition if your doctor is prescribed.
Driving
Caution
T3 Beta-AT Injection may make you feel sleepy, dizzy, or generally weak. In such cases, do not drive or operate machinery.
Liver
Caution
Close monitoring of patients with liver diseases while being treated with T3 Beta-AT Injection is required. Let your doctor know if you have any history of liver diseases before using T3 Beta-AT Injection. No specific dose adjustments are needed.
Kidney
Caution
Therapy with T3 Beta-AT Injection is to be cautiously administered in patients with renal impairment. Let your doctor know if you have any history of kidney diseases before using T3 Beta-AT Injection. No specific dose adjustments are needed.
Children
Safe if prescribed
T3 Beta-AT Injection is safely given to the children 6 months or older.
Country of origin
Product Substitutes